"programmed deathligand 1" trang 8 - tải miễn phí từ tailieunhanh
Survival benefit of pembrolizumab for patients with pancreatic adenocarcinoma: A case series

Survival benefit of pembrolizumab for patients with pancreatic adenocarcinoma: A case series
4    1    1
Steven-Johnson syndrome: A rare but serious adverse event of nivolumab use in a patient with metastatic gastric adenocarcinoma

Steven-Johnson syndrome: A rare but serious adverse event of nivolumab use in a patient with metastatic gastric adenocarcinoma
7    6    1
Pembrolizumab-induced myasthenia gravis and myositis: Literature review on neurological toxicities of programmed death protein 1 inhibitors

Pembrolizumab-induced myasthenia gravis and myositis: Literature review on neurological toxicities of programmed death protein 1 inhibitors
6    3    1
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
6    1    1
Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: A retrospective study

Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: A retrospective study
13    1    1
Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms

Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms
11    4    1
Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer

Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer
10    4    1
Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity

Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity
17    5    1
PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia

PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
9    5    1
E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis

E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis
11    8    1
A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation

A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation
15    1    1
Prevalence of immune-related adverse events and anti-tumor efcacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors

Prevalence of immune-related adverse events and anti-tumor efcacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors
9    10    1
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1

Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1
10    8    1
Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients

Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients
9    6    1
Ebook Xylem: Methods and protocols

Ebook Xylem: Methods and protocols
257    4    1
Ebook Microbial stress tolerance for biofuels: Systems biology

Ebook Microbial stress tolerance for biofuels: Systems biology
311    10    1
Ebook Medical terminology: A programmed systems approach (10/E): Part 1

Ebook Medical terminology: A programmed systems approach (10/E): Part 1
309    24    1
Ebook Medical terminology - A programmed systems approach (10/E): Part 2

Ebook Medical terminology - A programmed systems approach (10/E): Part 2
408    11    1
Ebook Solid base catalysis (Springer series in Chemical physics, Volume 101)

Ebook Solid base catalysis (Springer series in Chemical physics, Volume 101)
431    16    1
Ebook Acute neuronal injury: The role of excitotoxic programmed cell death mechanisms

Ebook Acute neuronal injury: The role of excitotoxic programmed cell death mechanisms
303    1    1